NO930163L - Inhibering av mac-1-reseptorbinding til fibrinogen ved anvendelse av d30-homologer - Google Patents

Inhibering av mac-1-reseptorbinding til fibrinogen ved anvendelse av d30-homologer

Info

Publication number
NO930163L
NO930163L NO93930163A NO930163A NO930163L NO 930163 L NO930163 L NO 930163L NO 93930163 A NO93930163 A NO 93930163A NO 930163 A NO930163 A NO 930163A NO 930163 L NO930163 L NO 930163L
Authority
NO
Norway
Prior art keywords
homologist
fibrinogen
mac
inhibition
receptor binding
Prior art date
Application number
NO93930163A
Other languages
English (en)
Other versions
NO930163D0 (no
Inventor
Dario Altieri
Edward F Plow
Thomas S Edgington
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO930163D0 publication Critical patent/NO930163D0/no
Publication of NO930163L publication Critical patent/NO930163L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO93930163A 1990-07-19 1993-01-18 Inhibering av mac-1-reseptorbinding til fibrinogen ved anvendelse av d30-homologer NO930163L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55664390A 1990-07-19 1990-07-19
US07/734,296 US5473051A (en) 1990-07-19 1991-07-18 Inhibition of Mac-1 receptor binding to fibrinogen using D30 homologs
PCT/US1991/005096 WO1992001464A1 (en) 1990-07-19 1991-07-19 Inhibition of mac-1 receptor binding to fibrinogen using d30 homologs

Publications (2)

Publication Number Publication Date
NO930163D0 NO930163D0 (no) 1993-01-18
NO930163L true NO930163L (no) 1993-03-19

Family

ID=27071209

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930163A NO930163L (no) 1990-07-19 1993-01-18 Inhibering av mac-1-reseptorbinding til fibrinogen ved anvendelse av d30-homologer

Country Status (10)

Country Link
US (1) US5473051A (no)
EP (1) EP0540675A4 (no)
JP (1) JPH05509322A (no)
AU (1) AU8425191A (no)
CA (1) CA2087169A1 (no)
FI (1) FI930191L (no)
IE (1) IE912528A1 (no)
NO (1) NO930163L (no)
PT (1) PT98398A (no)
WO (1) WO1992001464A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962795B1 (en) * 1992-05-11 2005-11-08 Dendreon Corporation Neutrophil inhibitors
US5599790A (en) 1992-06-11 1997-02-04 The Scripps Research Institute Fibrinogen γ chain polypeptide and compositions thereof
AU675073B2 (en) * 1992-06-11 1997-01-23 Scripps Research Institute, The Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
DE4242736A1 (de) * 1992-12-17 1994-06-23 Behringwerke Ag Synthetische Peptide, Antikörper dagegen und ihre Verwendung
WO1995005395A1 (en) * 1993-08-17 1995-02-23 Fujisawa Pharmaceutical Co., Ltd. Method of diagnosing alzheimer's disease
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
CA2180140A1 (en) * 1993-12-27 1995-07-06 Jeffrey I. Weitz Methods and compositions for inhibiting thrombogenesis
US6001809A (en) * 1994-07-11 1999-12-14 Elan Pharmaceuticals, Inc. Inhibitors of leukocyte adhesion
JP3323508B2 (ja) * 1994-10-25 2002-09-09 グラクソ グループ リミテッド Ｃｄ２３に対する結合物質
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them
US7122620B1 (en) * 1998-05-27 2006-10-17 Medical Research Services And Development Ltd. Haptotactic peptides
IL139604A0 (en) * 1998-05-27 2002-02-10 Hadasit Med Res Service Novel peptides
IL152609A0 (en) * 2002-11-03 2003-06-24 Hapto Biotech Inc Liposomal compositions comprising haptotactic peptides and uses thereof
US20080311103A1 (en) * 2004-03-08 2008-12-18 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Anti-Inflammatory Peptides and Methods of Use Thereof
JP4988599B2 (ja) * 2005-01-07 2012-08-01 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Ｉｇｆ−１融合ポリペプチドおよびその治療的使用
US7204310B1 (en) 2006-04-11 2007-04-17 Halliburton Energy Services, Inc. Methods of use settable drilling fluids comprising cement kiln dust
EP2265638A1 (en) 2008-04-14 2010-12-29 Hadasit Medical Research Services And Development Ltd. Stable cell binding chimeric peptides
US20100261224A1 (en) * 2009-04-10 2010-10-14 Felsher Dean W Discovery and validation of cancer biomarkers using a protein analysis methodology to analyze specimens
WO2014066655A2 (en) * 2012-10-25 2014-05-01 Oncosec Medical Incorporation Electroporation device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE68925923T2 (de) * 1988-06-10 1996-11-14 Merck & Co Inc Antigene der einzigen Spaltungsstelle von Fibrinogen durch Elastase
DE3819923A1 (de) * 1988-06-11 1989-12-21 Behringwerke Ag Fibrin(ogen)derivate, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
FI930191A7 (fi) 1993-03-18
WO1992001464A1 (en) 1992-02-06
FI930191L (fi) 1993-03-18
FI930191A0 (fi) 1993-01-18
JPH05509322A (ja) 1993-12-22
AU8425191A (en) 1992-02-18
NO930163D0 (no) 1993-01-18
PT98398A (pt) 1992-06-30
EP0540675A1 (en) 1993-05-12
US5473051A (en) 1995-12-05
IE912528A1 (en) 1992-01-29
CA2087169A1 (en) 1992-01-20
EP0540675A4 (en) 1993-07-14

Similar Documents

Publication Publication Date Title
NO930163D0 (no) Inhibering av mac-1-reseptorbinding til fibrinogen ved anvendelse av d30-homologer
NO172570C (no) Fremgangsmaate ved fremstilling av granulater
FI930861L (fi) Dehydrering av alkaner
DK412489A (da) Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren
DK0523829T3 (da) Fremgangsmåde til syntese af betazeolit
NO914449D0 (no) Fremgangsmaate ved fremstilling av celluloseholdig masse
NO933609D0 (no) Sammensetninger for reverserbar binding av oksygen
DK714588D0 (da) Syrelabile forankringsgrupper til syntese af peptidamider ved fastfasemetoden
NO874575L (no) Fremgangsmaate til fremstilling av fiberarmerte komposittmaterialer inneholdende polyarylensulfidsulfon.
NO923163L (no) Fremgangsmaate ved alkalitilsetning til tremasse
DK245590A (da) Fremgangsmaade til fremstilling af asfaltblandinger
NO872094D0 (no) Fremgangsmaate ved fremstilling av dbh-inhiberende forbindelser.
NO920938L (no) Fremgangsmaate til fremstilling av oksamid
NO910912L (no) Roerkonstruksjon av betong.
DK113897A (da) Fremgangsmåde til fremstilling af antihypercholesterolæmiske tetrazolforbindelser
NO932474D0 (no) Fremgangsmaate til fremstilling av oxamidgranulater
FI930219A7 (fi) Reaktioseosten käyttö valettavina massoina
NO870543L (no) Fremgangsmaate ved fremstilling av 4-acetylisokinolinonforbindelser.
DK0569701T3 (da) Fremgangsmåde til fremstilling af 2-amino-5-methyl-pyridin
IS3550A7 (is) Skilja til að aðskilja föst efni frá vökva
DK0599044T3 (da) Fremgangsmåde til fremstilling af chlorphenylphosphaner
DK39390D0 (da) Fremgangsmaade til fremstilling af konstruktionstrae
DK115088D0 (da) Indretning til sammensoemning af konstruktionsdele
DK14493D0 (da) Fremgangsmaade til fremstilling af pladeformede konstruktionselementer
NO864670L (no) Foringsmateriale til bruk ved gipsing av legemsdeler.